2 unchanged sentences
The following is a list of exhibits filed as part of this Quarterly Report on Form 10-Q.
−Removed: Where so indicated, exhibits that were previously
−Removed: filed are incorporated by reference.
+Added: Where so indicated, exhibits that were previously filed are incorporated by reference.
For exhibits incorporated by reference, the location of the exhibit in the previous filing is indicated.
1 unchanged sentence
Exhibit Description
+Added: Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc.
+Added: Piper Jaffray & Co., dated April 25, 2018.
+Added: April 26, 2018
Amended and Restated Certificate of Incorporation of Senesco Technologies, Inc.
5 unchanged sentences
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Senesco Technologies, Inc.
−Removed: filed with the State of Delaware
−Removed: on September 22, 2009.
+Added: filed with the State of Delaware on September 22, 2009.
March 16, 2018
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Senesco Technologies, Inc.
−Removed: filed with the State of Delaware
−Removed: on May 25, 2010.
+Added: filed with the State of Delaware on May 25, 2010.
March 16, 2018
Certificate of Amendment to the Amended and Restated Certificate of Incorporation Senesco Technologies, Inc.
−Removed: filed with the State of Delaware
−Removed: on December 22, 2011.
+Added: filed with the State of Delaware on December 22, 2011.
March 16, 2018
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Senesco Technologies, Inc.
−Removed: filed with the State of Delaware
−Removed: on April 1, 2013.
+Added: filed with the State of Delaware on April 1, 2013.
March 16, 2018
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware
−Removed: on October 16, 2013.
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on October 16, 2013.
March 16, 2018
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware
−Removed: on September 29, 2014.
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on September 29, 2014.
March 16, 2018
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware
−Removed: on December 19, 2017.
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on December 19, 2017.
March 16, 2018
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware
−Removed: on December 19, 2017.
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on December 19, 2017.
March 16, 2018
1 unchanged sentence
March 16, 2018
−Removed: Memorandum of Understanding, dated March 13, 2018, by and between Eloxx Pharmaceuticals, Inc.
−Removed: Silvia Noiman.
−Removed: March 16, 2018
−Removed: Employment Agreement, dated as of March 12, 2018, between Eloxx Pharmaceuticals Inc.
−Removed: and Gregory Weaver.
−Removed: March 16, 2018
−Removed: Employment Agreement, dated as of March 12, 2018, between Eloxx Pharmaceuticals Inc.
−Removed: and Pedro Huertas.
−Removed: March 16, 2018
+Added: Incorporated by Reference
+Added: Exhibit Description
Eloxx Pharmaceuticals, Inc.
1 unchanged sentence
March 30, 2018
+Added: Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Eloxx Pharmaceuticals, Inc.
+Added: 2018 Equity Incentive Plan
+Added: March 30, 2018
+Added: Form of Restricted Stock Unit Grant Notice for non-Israeli employees.
Israeli Sub-Plan under the Eloxx Pharmaceuticals, Inc.
1 unchanged sentence
March 30, 2018
−Removed: Certification of the Companys Chief Executive Officer pursuant to Rule 13a-14(a) and Rule
−Removed: 15d-14(a) of the Securities and Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of the Companys Chief Financial Officer pursuant to Rule 13a-14(a) and Rule
−Removed: 15d-14(a) of the Securities and Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Form of Israeli Stock Option Grant Package under the Israeli Sub-Plan under the Eloxx Pharmaceuticals, Inc.
+Added: 2018 Equity Incentive Plan.
+Added: March 30, 2018
+Added: Form of Restricted Stock Unit Grant Notice for Israeli employees.
+Added: Amendment to Research and License Agreement, by and among Eloxx Pharmaceuticals, Inc., Eloxx Pharmaceuticals Ltd.
+Added: and Technion Research & Development Foundation Ltd., dated as of June 13, 2018.
+Added: June 14, 2018
+Added: Lease amendment dated June 21, 2018.
+Added: June 26, 2018
+Added: Employment Agreement with Dr.
+Added: Greg Williams dated June 25, 2018.
+Added: June 26, 2018
+Added: Certification of the Company’s Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities and Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Certification of the Company’s Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities and Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of the Company’s Chief Executive Officer pursuant to 18 U.S.C.
5 unchanged sentences
XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: XBRL Taxonomy Extension Definition Linkbase Document.
+Added: Incorporated by Reference
+Added: Exhibit Description
+Added: XBRL Taxonomy Extension Definition Linkbase
XBRL Taxonomy Extension Label Linkbase Document.
1 unchanged sentence
Filed herewith.
+Added: Indicates a management contract or compensatory plan or arrangement required to be filed pursuant to Item 15(b) of Form 10-K.
This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C.
−Removed: Section 1350, and is not being filed for purposes of
−Removed: Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing of the registrant under the Securities Act of 1933, as
−Removed: amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
−Removed: the undersigned, thereunto duly authorized.
+Added: Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ELOXX PHARMACEUTICALS, INC.
+Added: August 9, 2018
/s/ Robert E.
1 unchanged sentence
(Principal Executive Officer)
+Added: August 9, 2018
/s/ Gregory Weaver
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.